What are the major opportunities in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market? What are the strategies for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

For detailed insights on the major opportunities and strategies in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market, Read More

How does the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market relate to the overall economy and other similar markets?

For detailed insights on Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market growth? SWOT analysis of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market.

For detailed insights on the key dynamics influencing the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market growth and SWOT analysis of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors industry, Read More

Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2025

Name: Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Invokana, Jardiance, Farxiga Or Forxiga, Suglat), By Route Of Administration (Oral Route, Other Route Of Administration), By End User (Hospitals, Homecare Settings, Clinics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

• Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market size has reached to $10.17 billion in 2024

• Expected to grow to $15.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: Rising Diabetes Prevalence Boosts Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market Growth

• Market Trend: Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes by blocking the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion in urine. This helps lower blood glucose levels and can also contribute to weight loss and reduced blood pressure. They have additional cardiovascular and renal benefits, making them valuable in managing diabetic complications.

The main types of sodium glucose cotransporter 2 (SGLT 2) inhibitors are invokana, Jardiance, farxiga or forxiga, and suglat. Invokana refers to a prescription medication used to lower blood sugar levels in adults with type 2 diabetes. These medications are typically administered through the oral route and others and are used by end users such as hospitals, homecare settings, and clinics.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size and growth rate 2025 to 2029: Graph

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size 2025 And Growth Rate?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market size has grown strongly in recent years. It will grow from $10.17 billion in 2024 to $10.96 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to early clinical trial successes, rising regulatory approvals, increasing diabetes diagnosis rates, and the demand for innovative diabetes treatments.

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth Forecast?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market size is expected to see strong growth in the next few years. It will grow to $15.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising diabetes prevalence, increasing obesity rates, growing awareness of diabetes management, and expanding applications in heart and kidney disease treatments. Major trends in the forecast period include the integration of combination therapies, personalized medicine approaches, technological improvement, and traditional drug development.

The forecast of 8.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of SGLT2 inhibitors for diabetes and heart failure sourced from India and Ireland, thereby limiting patient access to advanced therapies and elevating endocrinology and cardiology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmented?

1) By Type: Invokana, Jardiance, Farxiga Or Forxiga, Suglat

2) By Route Of Administration: Oral Route, Other Route Of Administration

3) By End User: Hospitals, Homecare Settings, Clinics

Subsegments:

1) By Invokana: Generic Invokana (Canagliflozin), Branded Invokana

2) By Jardiance: Generic Jardiance (Empagliflozin), Branded Jardiance

3) By Farxiga Or Forxiga: Generic Farxiga (Dapagliflozin), Branded Farxiga

4) By Suglat: Suglat (Sotagliflozin) For Diabetes, Suglat (Sotagliflozin) For Heart Failure

What Is Driving The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Rising Diabetes Prevalence Boosts Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market Growth

The increasing prevalence of diabetes is expected to propel the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor market going forward. Diabetes refers to a group of metabolic disorders characterized by high blood sugar levels resulting from defects in insulin secretion, insulin action, or both. The rise in diabetes cases can be attributed to factors such as urbanization, stress, environmental pollutants, and a lack of access to healthcare services. Sodium glucose cotransporter 2 (SGLT2) inhibitors are used in diabetes treatment to lower blood glucose levels by preventing glucose reabsorption in the kidneys, leading to its excretion in urine. They also offer cardiovascular and renal benefits, making them a valuable option for managing diabetes and its complications. For instance, in December 2023, according to Australian Bureau of Statistics, an Australian based government agency, in 2022, 5.3% of Australians, or about 1.3 million people, were diagnosed with diabetes, with rates similar between males (5.8%) and females (4.9%). Diabetes prevalence has been steadily increasing, significantly rising with age, reaching 18.7% among those aged 75 and older. Type 2 diabetes is the most common form, accounting for 87.6% of cases. Factors such as being born overseas, living in disadvantaged areas, and having a disability are associated with higher diabetes rates. Therefore, the increasing prevalence of diabetes is driving the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor industry.

Who Are The Major Players In The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

Major companies operating in the sodium glucose cotransporter 2 (SGLT2) inhibitors market are Pfizer Inc., Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmBH, Astellas Pharma Inc, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co. Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Limited, Glenmark pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co. Ltd., Patsnap Synapse, Kotobuki Pharmaceutical Co Ltd.

What Are The Key Trends Of The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management

Major companies operating in the sodium glucose cotransporter 2 (SGLT2) inhibitor market are focused on developing dual inhibitor therapeutic solutions to improve patient outcomes and manage blood sugar levels. Dual inhibitor therapeutic solutions refer to treatments that simultaneously target two different sodium-glucose cotransporters (SGLT1 and SGLT2) to enhance efficacy in managing conditions such as heart failure and diabetes. For instance, in May 2023, Lexicon Pharmaceuticals Inc., a US-based biopharmaceutical company, received approval from the Food and Drug Administration (FDA) for sotagliflozin, a treatment for heart failure. This first-in-class dual inhibitor of sodium-glucose cotransporters 1 and 2 is a once-daily tablet designed to reduce cardiovascular death, heart failure hospitalizations, and urgent heart failure visits in adults with heart failure, type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors. Its benefits include reduced renal glucose and sodium reabsorption, which leads to preload and afterload reduction and decreased sympathetic activity.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Strategic Partnerships Drive Innovation In Diabetes And Cardiovascular Treatments

In December 2022, Torrent Pharmaceuticals, an India-based pharmaceutical company, partnered with Boehringer Ingelheim International GmbH to co-market medicines used to treat diabetes and cardiovascular diseases. With this partnership, they aim to develop treatments for glycemic control in adults with type 2 diabetes mellitus. Empagliflozin also reduces the risk of cardiovascular death in those with type 2 diabetes and established cardiovascular disease and lowers the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. Boehringer Ingelheim International GmbH is a Germany-based pharmaceutical company that develops and manufactures human and animal health products.

What Is The Regional Outlook For The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market consists of sales of luseogliflozin, remogliflozin, tofogliflozin and sergliflozin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Industry?

The sodium glucose cotransporter 2 (sglt2) inhibitors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sodium glucose cotransporter 2 (sglt2) inhibitors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$10.96 billion
Revenue Forecast In 2034	$15.09 billion
Growth Rate	CAGR of 8.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Invokana, Jardiance, Farxiga Or Forxiga, Suglat 2) By Route Of Administration: Oral Route, Other Route Of Administration 3) By End User: Hospitals, Homecare Settings, Clinics Subsegments: 1) By Invokana: Generic Invokana (Canagliflozin), Branded Invokana 2) By Jardiance: Generic Jardiance (Empagliflozin), Branded Jardiance 3) By Farxiga Or Forxiga: Generic Farxiga (Dapagliflozin), Branded Farxiga 4) By Suglat: Suglat (Sotagliflozin) For Diabetes, Suglat (Sotagliflozin) For Heart Failure
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmBH, Astellas Pharma Inc, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co. Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Limited, Glenmark pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co. Ltd., Patsnap Synapse, Kotobuki pharmaceutical Co Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Characteristics

3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Trends And Strategies

4. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Growth Analysis And Strategic Analysis Framework

5.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth Rate Analysis

5.4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Total Addressable Market (TAM)

6. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmentation

6.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Invokana

Jardiance

Farxiga Or Forxiga

Suglat

6.2. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Route

Other Route Of Administrations

6.3. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare Settings

Clinics

6.4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic Invokana (Canagliflozin)

Branded Invokana

6.5. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic Jardiance (Empagliflozin)

Branded Jardiance

6.6. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Generic Farxiga (Dapagliflozin)

Branded Farxiga

6.7. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Suglat (Sotagliflozin) For Diabetes

Suglat (Sotagliflozin) For Heart Failure

7. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Regional And Country Analysis

7.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

8.1. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

9.1. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

9.2. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

10.1. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

11.1. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

11.2. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

12.1. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

13.1. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

14.1. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

14.2. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

15.1. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

15.2. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

16.1. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

17.1. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

18.1. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

19.1. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

20.1. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

21.1. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

21.2. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

22.1. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

23.1. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

23.2. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

24.1. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

24.2. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

25.1. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

25.2. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

26.1. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

26.2. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

27.1. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

28.1. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

28.2. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

29.1. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

29.2. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Landscape And Company Profiles

30.1. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Landscape

30.2. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. AstraZeneca plc

31.3. Eli Lilly and Company

31.4. Boehringer Ingelheim International GmBH

31.5. Astellas Pharma Inc

31.6. Daiichi Sankyo Company Limited

31.7. Sun Pharmaceutical Industries Ltd

31.8. Sumitomo Dainippon Pharma Co. Ltd.

31.9. Taisho Pharmaceutical Holdings Co. Ltd.

31.10. Lupin Limited

31.11. Glenmark pharmaceuticals

31.12. Torrent Pharmaceuticals Ltd

31.13. Mankind Pharma Ltd

31.14. Kissei Pharmaceutical Co. Ltd.

31.15. Patsnap Synapse

32. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

34. Recent Developments In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

35. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market High Potential Countries, Segments and Strategies

35.1 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2029 - Countries Offering Most New Opportunities

35.2 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2029 - Segments Offering Most New Opportunities

35.3 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Johnson & Johnson Inc. Financial Performance

Table 80: Merck & Co. Inc. Financial Performance

Table 81: Bayer AG Financial Performance

Table 82: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Johnson & Johnson Inc. Financial Performance

Figure 80: Merck & Co. Inc. Financial Performance

Figure 81: Bayer AG Financial Performance

Figure 82: Sanofi S.A. Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2025 – By Type (Invokana, Jardiance, Farxiga Or Forxiga, Suglat), By Route Of Administration (Oral Route, Other Route Of Administration), By End User...

View Report

Antidiabetics Global Market Report 2025 – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes,), By Diabetes Type (Type 1, Type 2), By Patient Population (Antidiabetic...

View Report

mTOR Inhibitors Global Market Report 2025 – By Product Type (Rapamune, Afinitor, Torisel, Zortress, Other Product Types), By Indication (Oncology, Immunosuppressant, Organ Transplantation, Other Indications), By Route of...

View Report

Kinase Inhibitors Global Market Report 2025 – By Type (Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By Application...

View Report

ACE Inhibitors Global Market Report 2025 – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipri...

View Report

Type 2 Diabetes Global Market Report 2025 – By Drug Class (Dipeptidyl Peptidase-4 (DPP-, Inhibitors, Glucagon-Like Peptide-1 (GLP-– Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And O...

View Report

Enzyme Inhibitor Global Market Report 2025 – By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, Othe...

View Report

Glucose Global Market Report 2025 – By Form (Syrup, Solid), By Source (Wheat, Corn, Other Sources), By Application (Food and Beverage, Pharmaceutical, Cosmetics, Personal Care, Pulp and Paper, Other Applications) – Impac...

View Report

Frequently Asked Questions

What is the definition of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

How will the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market drivers and restraints affect the market dynamics? What forces will shape the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors industry going forward?

The market major growth driver - Rising Diabetes Prevalence Boosts Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market Growth. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

The sodium glucose cotransporter 2 (sglt2) inhibitors market size has grown strongly in recent years. It will grow from $10.17 billion in 2024 to $10.96 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to early clinical trial successes, rising regulatory approvals, increasing diabetes diagnosis rates, and the demand for innovative diabetes treatments. The sodium glucose cotransporter 2 (sglt2) inhibitors market size is expected to see strong growth in the next few years. It will grow to " $15.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising diabetes prevalence, increasing obesity rates, growing awareness of diabetes management, and expanding applications in heart and kidney disease treatments. Major trends in the forecast period include the integration of combination therapies, personalized medicine approaches, technological improvement, and traditional drug development. For further insights on this market, request a sample here

How is the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market segmented?

The sodium glucose cotransporter 2 (sglt2) inhibitorsmarket covered in this report is segmented –
1) By Type: Invokana; Jardiance; Farxiga Or Forxiga; Suglat
2) By Route Of Administration: Oral Route; Other Route Of Administration
3) By End User: Hospitals; Homecare Settings; Clinics Subsegments:
1) By Invokana: Generic Invokana (Canagliflozin); Branded Invokana
2) By Jardiance: Generic Jardiance (Empagliflozin); Branded Jardiance
3) By Farxiga Or Forxiga: Generic Farxiga (Dapagliflozin); Branded Farxiga
4) By Suglat: Suglat (Sotagliflozin) For Diabetes; Suglat (Sotagliflozin) For Heart Failure For further insights on this market, request a sample here

Which region has the largest share of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market? What are the other regions covered in the report?

North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sodium glucose cotransporter 2 (SGLT2) inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

What are the key trends in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

Major trends in this market include Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Global Market Report 2025

By Type (Invokana, Jardiance, Farxiga Or Forxiga, Suglat), By Route Of Administration (Oral Route, Other Route Of Administration), By End User (Hospitals, Homecare Settings, Clinics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

What Is Covered Under Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size 2025 And Growth Rate?

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmented?

What Is Driving The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Rising Diabetes Prevalence Boosts Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market Growth

Who Are The Major Players In The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

What Are The Key Trends Of The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management

What Are Latest Mergers And Acquisitions In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market? Strategic Partnerships Drive Innovation In Diabetes And Cardiovascular Treatments

What Is The Regional Outlook For The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

What Defines the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Industry?

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions